A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod

2013-06-01

British Journal of Dermatology , Volume 168 - Issue 6 p. 1362- 1364

Additional Metadata
Keywords	ablation therapy, adult, aged, clinical article, clinical evaluation, drug withdrawal, female, follow up, histopathology, human, human tissue, inflammation, inflammatory pain, letter, low level laser therapy, male, malignant lentigo, priority journal, recurrent disease, treatment duration, treatment outcome
Persistent URL	doi.org/10.1111/bjd.12157, hdl.handle.net/1765/41000
Journal	British Journal of Dermatology
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	de Vries, K., Rellum, R., Habets, J. M. W., & Prens, E. (2013). A novel two-stage treatment of lentigo maligna using ablative laser therapy followed by imiquimod. British Journal of Dermatology, 168(6), 1362–1364. doi:10.1111/bjd.12157

Publication